leadership
confidence high
sentiment neutral
materiality 0.35
Director Jay Panis resigns from Virpax board and committees, effective Feb 3, 2025
Virpax Pharmaceuticals, Inc.
- Jay Panis resigned from the Board and all committees (Audit, Compensation, Nominating/Governance).
- Resignation due to compliance requirements with his current employer, not due to any disagreement with company.
- Company will begin process to identify a qualified independent director to fill the vacancy.
- No other director departures or executive officer changes reported.